Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CB1 agonists(Cannabinoid CB1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H15F3N2O2 |
InChIKeyHTKWVAWIVNAHFB-UHFFFAOYSA-N |
CAS Registry2589617-40-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | 03 Jan 2020 |